DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
CALGB/SWOG C80405: A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum.
Clin Adv Hematol Oncol 2006;
4: 452-453
Access:
We do not assume any responsibility for the contents of the web pages of other providers.